It is widely accepted that mutant forms of p53 can exert dominant negative or gain-of-function effects that contribute to tumour development beyond that seen following loss of the wild-type p53 protein alone (Blagosklonny, 2000; Sigal and Rotter, 2000). The gene discussed is TP53; the disease is neoplasm.